TBCRC 002: A Phase II, Randomized, Open-Label Trial of Preoperative Letrozole With or Without Bevacizumab in Postmenopausal Women With Newly Diagnosed Stage 2/3 Hormone Receptor-Positive and HER2-negative Breast Cancer
Breast Cancer Research - United Kingdom
doi 10.1186/s13058-020-01258-x
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
Springer Science and Business Media LLC